# Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma

> **NCT01086488** · PHASE2 · UNKNOWN · sponsor: **Ministry of Health, Malaysia** · enrollment: 66 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** FOSCAN

## Key facts

- **NCT ID:** NCT01086488
- **Lead sponsor:** Ministry of Health, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2011-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086488, "Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01086488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*